4-70202789-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017855.4(ODAM):c.682G>A(p.Glu228Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000048 in 1,459,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017855.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ODAM | NM_017855.4 | c.682G>A | p.Glu228Lys | missense_variant | 10/12 | ENST00000683306.1 | |
ODAM | NM_001385579.1 | c.634G>A | p.Glu212Lys | missense_variant | 9/11 | ||
ODAM | XM_047415863.1 | c.733G>A | p.Glu245Lys | missense_variant | 10/11 | ||
ODAM | XM_047415864.1 | c.691G>A | p.Glu231Lys | missense_variant | 9/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ODAM | ENST00000683306.1 | c.682G>A | p.Glu228Lys | missense_variant | 10/12 | NM_017855.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248822Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134598
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1459354Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 726008
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2023 | The c.682G>A (p.E228K) alteration is located in exon 9 (coding exon 9) of the ODAM gene. This alteration results from a G to A substitution at nucleotide position 682, causing the glutamic acid (E) at amino acid position 228 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at